RE: Pembrolizumab1 Jun 2025 10:13
probably nothing. i'm not interested in the validation of asset managers and for what it's worth this stock won't fit the mandate of 99% of portfolios therefore they won't be compelled to hold it.
some may dip in and out therefore it's no great shakes.
asset managers will be interested with this becomes a revenue generating asset, perhaps once a deal lands, mainly due to the fact that they want consistent, predictable returns. until then, it's high risk high potential play with a lot of volatility.
there's a **** ton of assets out there as well. but for us, we're here, interested and invested.
but you'd know that too. right?